Home » Topics » Regulatory

Regulatory
RSS

CysLT1 antagonists show potential as Rx for chronic urticaria

March 15, 1999

Effexor XR receives FDA approval for treatment of GAD

March 15, 1999

FDA okays new indication and minimal liver function testing for Lescol

March 12, 1999

Repligen to develop novel treatment for autism; clinical trials slated to begin this year

March 11, 1999

FDA approves new therapy for type II diabetes

March 10, 1999

FDA approves controlled-release form of popular antidepressant

March 8, 1999

Bupropion more effective than nicotine patches in smoking cessation therapy

March 8, 1999

Novartis obtains first western approval for new antimalarial drug combination

March 4, 1999

Pfizer claims new, improved compositions of alatrofloxacin

March 4, 1999

Glaxo Wellcome seeks approval for Zyban in the E.U.

March 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...